Gsk (GSK) Free Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Gsk (GSK) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn | 19.08% |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn | 22.20% |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.38% |
| Mar 31, 2026 | 74.15% |
| Dec 31, 2025 | -1.64% |
| Sep 30, 2025 | 21.77% |
| Jun 30, 2025 | 20.25% |
| Mar 31, 2025 | -19.10% |
| Dec 31, 2024 | -16.55% |
| Sep 30, 2024 | -6.56% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | 27.76% |
| Dec 31, 2023 | -29.56% |
| Sep 30, 2023 | -15.37% |
| Jun 30, 2023 | -18.49% |
| Mar 31, 2023 | -38.43% |
| Dec 31, 2022 | -4.21% |
| Sep 30, 2022 | -18.15% |
| Jun 30, 2022 | -5.61% |
| Mar 31, 2022 | 40.84% |
| Dec 31, 2021 | 11.46% |
| Sep 30, 2021 | 8.11% |